Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Uhl

Showing results (191-200 of 241) with videos related to

Pageof 25
Sort By:
Pancreas|January 1, 1995
Lipid peroxidation and glutathione metabolism in chronic pancreatitisM H Schoenberg, M Büchler, C Pietrzyk, et al.
Der Internist|September 3, 2017
[Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports]T G K Breuer, K Kampmann, A Wutzler, et al.
Gut|March 1, 1997
Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in ratsW Uhl, H J Schrag, N Schmitter, et al.
BMC Cancer|March 26, 2017
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivoM Buchholz, B Majchrzak-Stiller, S Hahn, et al.
The British Journal of Surgery|April 1, 2005
Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term resultsC A Seiler, M Wagner, T Bachmann, et al.
Diabetologia|November 28, 2008
Metabolic consequences of a 50% partial pancreatectomy in humansB A Menge, H Schrader, T G K Breuer, et al.
Gut|May 1, 1996
Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the ratB Hofbauer, H Friess, A Weber, et al.
Gastroenterology|April 1, 1993
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study GroupM Büchler, P Malfertheiner, W Uhl, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 6, 2006
[(section sign) 115 b SGB V threatens outpatient treatment for inguinal hernia. Analysis of outcome and economics]D Weyhe, C Winnemöller, A Hellwig, et al.
The Clinical Investigator|October 1, 1994
Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study GroupJ Briegel, W Kellermann, H Forst, et al.
Pageof 25

Showing results (191-200 of 241) with videos related to

Sort By:
Pageof 25
Pancreas|January 1, 1995
Lipid peroxidation and glutathione metabolism in chronic pancreatitisM H Schoenberg, M Büchler, C Pietrzyk, et al.
Der Internist|September 3, 2017
[Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports]T G K Breuer, K Kampmann, A Wutzler, et al.
Gut|March 1, 1997
Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in ratsW Uhl, H J Schrag, N Schmitter, et al.
BMC Cancer|March 26, 2017
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivoM Buchholz, B Majchrzak-Stiller, S Hahn, et al.
The British Journal of Surgery|April 1, 2005
Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term resultsC A Seiler, M Wagner, T Bachmann, et al.
Diabetologia|November 28, 2008
Metabolic consequences of a 50% partial pancreatectomy in humansB A Menge, H Schrader, T G K Breuer, et al.
Gut|May 1, 1996
Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the ratB Hofbauer, H Friess, A Weber, et al.
Gastroenterology|April 1, 1993
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study GroupM Büchler, P Malfertheiner, W Uhl, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 6, 2006
[(section sign) 115 b SGB V threatens outpatient treatment for inguinal hernia. Analysis of outcome and economics]D Weyhe, C Winnemöller, A Hellwig, et al.
The Clinical Investigator|October 1, 1994
Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study GroupJ Briegel, W Kellermann, H Forst, et al.
Pageof 25